11 completed, 5 recruiting, 3 unknown, 1 active not recruiting. 2 Not applicable, 2 Phase 2, 1 Early Phase 1, 1 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Not applicable | 2 | Completed 1, Unknown 1 |
| Phase 2 | 2 | Completed 1, Withdrawn 1 |
| Early Phase 1 | 1 | Completed 1 |
| Phase 1 | 1 | Withdrawn 1 |
| Phase 3 | 1 | Recruiting 1 |
Follow Dysplastic Nevus Syndrome: new trials by email Literature Review of Dysplastic Nevus Syndrome trials Research Report on Dysplastic Nevus Syndrome
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Effects of Anti-PD1 Adjuvant Checkpoint Blockade Immunotherapy on Atypical/Dysplastic Nevi Single agent, adjuvant anti-PD1 therapy - Melanoma | Recruiting | John Kirkwood | 30 | 2025-02-20 | 2026-01-26 | |
| INTER-PATHOLOGIST READER STUDY Nevi, Dysplastic | Unknown | Orlucent, Inc | 500 | 2023-06-15 | 2024-02-07 | |
| The Pancreas Interception Center (PIC) for Early Detection, Prevention, and Novel Therapeutics Data collection - Pancreatic Ductal Adenocarcinoma, Pancreatic Cyst | Active not recruiting | H. Lee Moffitt Cancer Center and Research Institute | 317 | 2022-10-06 | 2026-09-15 | |
| Skin Fluorescent Imaging (SFI) System in Patients With Nevi Skin Fluorescent Imaging - Nevus, Dysplasia; Epithelial | Completed | Orlucent, Inc | 300 | 2020-08-10 | 2025-08-07 | |
| Atypical MOLes and Melanoma Early Detection Study (MoleMed) Non-invasive adhesive system (patch) - Melanoma, Melanoma (Skin) | Not applicable | Unknown | Russian Academy of Medical Sciences | 350 | 2020-04-01 | 2022-06-14 |
| Registry of Subjects at Risk of Pancreatic Cancer MRCP, Endoultrasonography - Familial Pancreatic Cancer, BRCA1 Mutation | Recruiting | Associazione Italiana per lo Studio del Pancreas | 1000 | 2019-08-20 | 2023-01-13 | |
| Use of Electrical Impedance Spectroscopy (EIS) for Early Diagnosis of Skin Damage Electrical Impedence Spectroscopy DermaSense - Melanoma (Skin), Basal Cell Carcinoma | Terminated | Aristotle University Of Thessaloniki | 50 | 2019-07-17 | 2023-07-25 | |
| Internet-based Intervention for Skin Self-Examination in Participants With Increased Risk for Melanoma Best Practice, mySmartCheck, Survey Administration - Dysplastic Nevus, Health Status Unknown | Not applicable | Completed | Rutgers, The State University of New Jersey | 116 | 2018-11-03 | 2022-11-14 |
| Assessing Tissue Remodeling in the Skin Using SFI (Skin Fluorescence Imaging) Diagnostic Test - Skin Lesion, Melanoma (Skin) | Completed | Orlucent, Inc | 186 | 2018-01-24 | 2024-01-10 | |
| Artificial Intelligence-assisted Evaluation of Pigmented Skin Lesions dermoscopy - Melanoma, Pigmented Skin Lesion | Unknown | Assuta Hospital Systems | 80 | 2017-12-06 | 2018-09-13 | |
| A Study of IMMray™ PanCan-d Test for Early Detection of Pancreatic Cancer in High-risk Groups Pancreatic Ductal Adenocarcinoma, Familial Pancreatic Cancer | Completed | Immunovia, Inc. | 1349 | 2016-01-19 | 2022-03-31 | |
| Pancreatic Cancer Early Detection Program Endoscopic Ultrasound, Magnetic Resonance Imaging (MRI) - Pancreatic Cancer, Pancreas Cancer | Completed | White Plains Hospital | 181 | 2014-04-01 | 2026-08-25 | |
| The Cancer of the Pancreas Screening-5 CAPS5)Study Secretin, MRI, Tumor marker gene test with CA19-9 - Pancreas Cancer, Peutz-Jeghers Syndrome (PJS) | Phase 3 | Recruiting | Johns Hopkins University | 9000 | 2014-01-06 | 2026-10-22 |
| BioMEL- Diagnostic and Prognostic Factors in Melanoma. Imaging - Melanoma, Melanoma in Situ | Recruiting | Region Skane | 2000 | 2013-11-04 | 2024-01-23 | |
| Prospective Study of 2 mm Margins for the Biopsy of Dysplastic Nevi Saucerization biopsy - Dysplastic Nevi | Completed | NYU Langone Health | 138 | 2013-02-25 | 2019-05-08 | |
| Pilot Study Evaluating Sulforaphane in Atypical Nevi-Precursor Lesions broccoli sprout extract - sulforaphane (BSE-SFN) - Atypical Nevi, Melanoma | Early Phase 1 | Completed | John Kirkwood | 17 | 2012-08-01 | 2018-01-09 |
| Potential Research Study Participant Registry Acne, Actinic Keratosis | Completed | University of California, Davis | 265 | 2008-05-01 | 2019-02-15 | |
| Photochemical Tissue Bonding tissue bonding, sutures - Basal Cell Carcinoma, Squamous Cell Carcinoma | Phase 2 | Completed | Massachusetts General Hospital | 40 | 2007-09-01 | 2009-04-10 |
| Evaluation of 20% Betulinic Acid Ointment for Treatment of Dysplastic Nevi (Moderate to Severe Dysplasia) 20% betulinic acid ointment, BA - Dysplastic Nevus Syndrome | Phase 1 / Phase 2 | Withdrawn | University of Illinois at Chicago | 2006-01-01 | 2021-06-28 | |
| Clinical, Laboratory, and Epidemiologic Characterization of Individuals and Families at High Risk of Melanoma Melanoma, Dysplastic Nevus Syndrome | Recruiting | National Cancer Institute (NCI) | 3000 | 2002-07-01 | 2026-10-02 |
Showing 20 of 22. Sign in to see all of them.
Melanoma (12) · Nevus (5) · Colorectal Neoplasms, Hereditary Nonpolyposis (4) · Peutz-Jeghers Syndrome (4) · Skin Neoplasms (4) · Carcinoma, Basal Cell (3) · Carcinoma, Squamous Cell (3) · Hereditary pancreatitis (3) · Pancreatic Neoplasms (3) · Pancreatic carcinoma, familial (3) · Hereditary Sensory and Autonomic Neuropathies (2) · Keratosis, Seborrheic (2) · Nevus, Pigmented (2) · Acne Vulgaris (1)
Congenital, Hereditary, and Neonatal Diseases and Abnormalities (22) · Genetic Diseases, Inborn (22) · Neoplasms by Histologic Type (22) · Neoplastic Syndromes, Hereditary (22) · Nevi and Melanomas (22) · Neoplasms (21) · Neoplasms by Site (19) · Skin Diseases (18) · Skin and Connective Tissue Diseases (18) · Nevus (17) · Neoplasms, Germ Cell and Embryonal (12) · Neoplasms, Nerve Tissue (12) · Neuroectodermal Tumors (12) · Neuroendocrine Tumors (12) · Skin Neoplasms (10)
Dermoscopy (2) · Betulinic Acid (1) · CA-19-9 Antigen (1) · Data Collection (1) · Diagnostic Imaging (1) · Endoscopic Ultrasound-Guided Fine Needle Aspiration (1) · Genome (1) · Magnetic Resonance Spectroscopy (1) · Nivolumab (1) · Pharmaceutical Preparations (1) · Practice Guidelines as Topic (1) · Secretin (1) · Standard of Care (1) · Sutures (1) · Transdermal Patch (1)
Orlucent, Inc (3) · John Kirkwood (2) · National Cancer Institute (NCI) (2) · Aristotle University Of Thessaloniki (1) · Associazione Italiana per lo Studio del Pancreas (1) · Assuta Hospital Systems (1) · H. Lee Moffitt Cancer Center and Research Institute (1) · Immunovia, Inc. (1) · Johns Hopkins University (1) · Massachusetts General Hospital (1) · NYU Langone Health (1) · Region Skane (1) · Russian Academy of Medical Sciences (1) · Rutgers, The State University of New Jersey (1) · University of California, Davis (1)
United States (16) · Italy (2) · Spain (2) · Sweden (2) · Canada (1) · Greece (1) · Israel (1) · Russia (1) · United Kingdom (1)
Cathy Shachaf, PhD (3) · John M Kirkwood, MD (2) · Avi Dascalu, MD. Ph.D. (1) · David Polsky, MD, PhD (1) · Emmanouil Papanastasiou, Dr. (1) · Fu-Tong Liu, M.D., Ph.D. (1) · Igor V Samoylenko, MD, PhD (1) · Irene E Kochevar, PhD (1) · John S Nelson, M.D,Ph.D (1) · Kari Nielsen, Ass. Prof. (1) · Maria T Landi, M.D. (1) · Michael Goggins, MD (1) · Michael R Sargen, M.D. (1) · Shaffer Mok, MD, MBS (1)
PMID 22032650, PMID 28982585, PMID 29408205, PMID 30538291, PMID 30674442, PMID 31101596, PMID 31197699, PMID 31326397, PMID 31676359, PMID 33161160, PMID 33811164, PMID 34149034, PMID 34637495, PMID 34643612, PMID 35166713, PMID 37099777, PMID 37787643, PMID 38309755
P30CA072720 (1), R01CA176828 (1), U01CA210170 (1)